Helena C van Doorn

25PUBLICATIONS
99CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 24, 2025
Poor accuracy of endometrial sampling in patients with uterine carcinosarcomas: a nationwide analysis.

Eveline N B Pham, Caroline B van den Berg, Rachel van Es

|Jan 17, 2025
Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference Trial.

Majke H D Van Bommel, Miranda P Steenbeek, Joanna Inthout

|Nov 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

Iris A S Stroot, Joost Bart, Harry Hollema

|Nov 11, 2024
High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands.

R L O van de Laar, C C E Jordans, A Salmaan

|Jun 23, 2024
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study.

M I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn

|May 02, 2024
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study.

Laura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven

Pageof 5